# Boditech Med

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/boditech-med

- Industry: Medical Devices & Equipment
- Headquarters: South Korea
- Website: www.boditech.co.kr
- Total disclosed funding: $1.8M
- Latest round: Series A (Nov 22, 2012)
- Investors on record: 1

## About

Based in Chuncheon, South Korea, and founded in 1998, Boditech Med Inc. operates as a manufacturer of point-of-care testing (POCT) products. In April 2022, CPC Diagnostics Pvt. Ltd., a portfolio company of Everlife Holdings Pte Ltd, Everstone Capital Partners, and HBM Partners, acquired the I-Chroma brand business of Weldon Biotech, Inc.

The company offers a diversified range of products such as reagents for various health conditions like cardiac, cancer, hormone, diabetes, infection, liver function, and many more. Additionally, the firm offers various instruments which produce reliable test results anytime anywhere such as AFIAS-1, AFIAS-3,ichroma-50, ichroma-II, ExAmplar, and many more. Furthermore, the company also provides a smart guide that helps in finding the best solutions for the patient’s symptoms.

The April 2022 acquisition may enable the company to introduce its EZ-POC brand in India.

## Funding rounds

- Series A, Nov 22, 2012, $1.8M — WOORI Venture Partners

## Investors

- WOORI Venture Partners (https://capitalatlas.ai/funds/woori-venture-partners) — Series A